Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories has informed that the audit of its API manufacturing plant at Srikakulam, Andhra Pradesh (CTO VI), by the US FDA, has been completed on January 28, 2020. The company has been issued a Form 483 with 5 observations. It will address them comprehensively within the stipulated timeline.

The above information is a part of company’s filings submitted to BSE.